Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Expert Rev Clin Pharmacol. 2017 Oct 12;11(2):151–164. doi: 10.1080/17512433.2017.1353909

Figure 3. Rapid genetic assays for CYP2C19.

Figure 3

A. SpartanRx™ (Spartan Bioscience, Ottawa, Canada) and B. the Verigene® System (Nanosphere, Northbrook, Illinois)